ESAB will begin trading on the N.Y. stock exchange April 5, according to a news release. About 54 million shares of ESAB common stock were distributed to Enovis shareholders.
The spinoff was announced in November, along with a new name for the orthopedic business, from Colfax to Enovis. In 2019, Colfax acquired devicemaker DJO.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
